跳至主要内容
临床试验/NCT05032404
NCT05032404已完成不适用

BNT 103 Usability and User Engagement

Blue Note Therapeutics1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2021年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
15
试验地点
1
主要终点
Mean mHealth App Usability Questionnaire (MAUQ) for Standalone mHealth Apps Used by Patients

研究概览

简要总结

This test aims to explore product development-focused usability and user engagement.

详细描述

Sponsor is testing an innovative peer-to-peer communication tool during this trial.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
35 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Patient can read, write, and speak in English
  • •Patient is between the ages of 35-55
  • •Diagnosed with Stage I-III breast cancer
  • •In active treatment or within 3 months of ending active treatment and under the care of a clinician at time of study
  • •Apple mobile phone or tablet user
  • •Willing to participate in study protocol

排除标准

  • •Any participant not meeting inclusion criteria

研究组 & 干预措施

BNT103

Experimental

All participants receive BNT103. BNT103 provides 10 sessions over approximately 10 weeks.

干预措施: BNT103 (Device)

结局指标

主要结局

Mean mHealth App Usability Questionnaire (MAUQ) for Standalone mHealth Apps Used by Patients

时间窗: Baseline up to Week 7

Higher scores indicate higher ease of use / easier to use applications

次要结局

  • Measure of Current Status - Anxiety (MOCS-A)(Baseline up to Week 7)

研究者

发起方
Blue Note Therapeutics
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Blue Note Therapeutics Product BNT 103 Usability and... | 临床试验